Giorgio LottiHead of the R&D Pipeline and Portfolio Leadership, Rare Diseases at ChiesiSpeaker
Agenda Sessions
A New Landscape: The EU HTA Regulation Impact on Biotech and Pharma in Europe
, 14:00View Session